Description
An inhibitor of the Lin28/let-7 interaction (IC50 = 8 μM in a competition ELISA); increases levels of endogenous let-7 miRNAs and decreases Lin28 expression in a dose-dependent manner in mESCs; inhibits clonogenic growth of 22Rv1, PC3, DU145, and Huh7 cancer cells and decreases tumor-sphere formation by 22Rv1 and Huh7 cells in vitro; binds BRD4 and CBP bromodomains (Kds = 7 and 25 μM, respectively)
Formal name: N-methyl-N-[3-(3-methyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]-acetamide
Synonyms:
Molecular weight: 281.3
CAS: 108825-65-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cancer Stem Cell Research||Research Area|Epigenetics, Transcription, & Translation|Readers|Bromodomains